Style de citation APA

Rose, E., Magliulo, D., & Kyttaris, V. C. (2022). Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose. Clinical immunology (Orlando, Fla.), 245, 109144. https://doi.org/10.1016/j.clim.2022.109144

Style de citation Chicago

Rose, Emily, Daniel Magliulo, et Vasileios C. Kyttaris. "Seroconversion Among Rituximab-treated Patients Following SARS-CoV-2 Vaccine Supplemental Dose." Clinical Immunology (Orlando, Fla.) 245 (2022): 109144. https://dx.doi.org/10.1016/j.clim.2022.109144.

Style de citation MLA

Rose, Emily, et al. "Seroconversion Among Rituximab-treated Patients Following SARS-CoV-2 Vaccine Supplemental Dose." Clinical Immunology (Orlando, Fla.), vol. 245, 2022, p. 109144.